ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Defiance Daily Target 2X Long MRNA ETF
103.09
+23.14
28.94%
盤後：
101.65
-1.4400
-1.40%
17:12 EDT
成交量：
99.72萬
成交額：
9,762.62萬
市值：
3,092.70萬
市盈率：
- -
高：
105.71
開：
85.01
低：
82.51
收：
79.95
52周最高：
143.84
52周最低：
14.95
股本：
30.00萬
流通股本：
30.00萬
量比：
0.67
換手率：
332.40%
股息：
- -
股息率：
- -
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
Moderna預期其第五款產品Mflusiva將於8月5日迎來PDUFA審批關鍵節點
美股速递
·
07/31
Moderna宣佈首例患者接受針對實體瘤的研究性腫瘤靶向癌症抗原療法一期臨床試驗
美股速递
·
07/16
ETF日報｜2倍做多Cerebras Systems ETF漲近17%；2倍做多Meta ETF漲12%；材料與地產帶動行業走強
ETF追踪
·
07/11
ETF日報｜2倍沽空閃迪ETF 漲逾28%；三倍沽空半導體ETF 漲近17%；成長承壓、貴金屬走強
ETF追踪
·
07/03
莫德納股價因自身免疫性疾病新研究計劃而上漲
投资观察
·
06/27
Moderna股價因流感疫苗獲推薦而上漲
投资观察
·
06/19
Moderna宣佈FDA諮詢委員會一致支持其季節性流感候選疫苗mRNA-1010的獲益-風險特徵
美股速递
·
06/19
Moderna有意在德國設立生產基地 尤其關注BioNTech工廠
美股速递
·
06/17
FDA工作人員初步評估：Moderna流感疫苗數據或支持65歲及以上成人有效性
美股速递
·
06/16
Moderna組織架構調整 為2027及2028年多款產品上市鋪路
投资观察
·
06/16
Moderna預計2027至2028年可能推出多達三款新產品，涵蓋流感新冠聯合疫苗、季節性流感及諾如病毒疫苗
美股速递
·
06/16
Moderna任命Ester Banque為首席商務官，2026年6月15日生效
美股速递
·
06/16
Moderna總裁斯蒂芬·霍格擴大職責範圍，將負責傳染病、Intismeran及罕見病業務板塊的運營監督
美股速递
·
06/16
Moderna與CEPI深化戰略合作 共同推進布迪布焦埃博拉病毒候選疫苗研發
美股速递
·
06/01
Moderna獲CEPI高達5000萬美元資助，用於推進BDBV候選疫苗臨床前研發與一期臨床試驗
美股速递
·
06/01
美國FDA顧問投票支持建議2026-27年度新冠疫苗以Jn.1譜系Xfg變異株為靶點
美股速递
·
05/29
Moderna公司計劃於八月中旬前備妥2026-27年度推薦新冠疫苗組分供應
美股速递
·
05/28
個股聚焦：Moderna、英特爾、MidCap Financial Investment
投资观察
·
05/11
Moderna國際新冠疫苗銷售超預期 一季度業績亮眼
投资观察
·
05/01
Moderna高管稱公司正等待FDA指導 以恢復流感-新冠聯合疫苗美國申報流程
美股速递
·
05/01
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/MRNX/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":103.09,"timestamp":1787688000000,"preClose":79.95,"halted":0,"volume":997211,"hourTrading":{"tag":"盘后","latestPrice":101.65,"preClose":103.09,"latestTime":"17:12 EDT","volume":2955,"amount":301374.46908,"timestamp":1787692326966,"change":-1.44,"changeRate":-0.013968,"amplitude":0.014841},"delay":0,"changeRate":0.2894308943089431,"floatShares":300000,"shares":300000,"eps":0,"marketStatus":"盤後交易","change":23.14,"latestTime":"08-25 17:22:12 EDT","open":85.01,"high":105.71,"low":82.512,"amount":97626159.1312,"amplitude":0.290156,"askPrice":102.8,"askSize":200,"bidPrice":101.6,"bidSize":15,"shortable":0,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":79.95,"sharesOutstanding":30000,"nav":87.68,"aum":26304000,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":85.58,"preClose":79.95,"latestTime":"09:28 EDT","volume":6477,"amount":544744.06926,"timestamp":1787664533763,"change":5.63,"changeRate":0.070419,"amplitude":0.066917},"postHourTrading":{"tag":"盘后","latestPrice":101.65,"preClose":103.09,"latestTime":"17:12 EDT","volume":2955,"amount":301374.46908,"timestamp":1787692326966,"change":-1.44,"changeRate":-0.013968,"amplitude":0.014841},"volumeRatio":0.667186},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":300000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.667186,"shares":300000,"dividePrice":0,"high":105.71,"amplitude":0.290156,"preClose":79.95,"low":82.512,"week52Low":14.95,"pbRate":"--","week52High":143.84,"institutionHeld":0,"latestPrice":103.09,"committee":-0.860465,"eps":0,"divideRate":0,"volume":997211,"delay":0,"ttmEps":0,"open":85.01,"prevYearClose":20.61,"prevWeekClose":87.53,"prevMonthClose":24.27,"prevQuarterClose":42.65,"fiveDayClose":31.33,"twentyDayClose":25.355,"sixtyDayClose":21.0089},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1145717315","title":"Moderna預期其第五款產品Mflusiva將於8月5日迎來PDUFA審批關鍵節點","url":"https://stock-news.laohu8.com/highlight/detail?id=1145717315","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145717315?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:02","pubTimestamp":1785495774,"startTime":"0","endTime":"0","summary":"Moderna公司近日释放积极信号，预计其第五款产品——针对Mflusiva的疗法，有望在今年8月5日的PDUFA日期获得监管批准。这一日期标志着FDA对该药物申请的最终审查期限，若顺利通关，将成为Moderna产品管线中的又一重要里程碑。目前，市场正密切关注这一审批进程，期待它为生物医药领域注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4548","BK4588","MRNY","LGHT","MRNX","BK4501","BK4533","MRNA","BK4551","BK4585","WDNA","BK4139","BK4568","GNOM","IDNA","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107107295","title":"Moderna宣佈首例患者接受針對實體瘤的研究性腫瘤靶向癌症抗原療法一期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1107107295","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107107295?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 19:42","pubTimestamp":1784202143,"startTime":"0","endTime":"0","summary":"Moderna, Inc.宣布，其研究性肿瘤靶向癌症抗原疗法在针对实体瘤的一期临床试验中，已为首例患者完成给药。该试验旨在评估该疗法的安全性与初步疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","MRNX","BK4533","LGHT","WDNA","GNOM","BK4548","BK4532","MRNA","BK4551","IDNA","MRNY","BK4534","BK4585","BK4588","BK4139","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133823051","title":"ETF日報｜2倍做多Cerebras Systems ETF漲近17%；2倍做多Meta ETF漲12%；材料與地產帶動行業走強","url":"https://stock-news.laohu8.com/highlight/detail?id=1133823051","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133823051?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 06:02","pubTimestamp":1783720938,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5$2倍做多CBRS ETF-Leverage Shares$上涨16.78%。该产品两倍做多AI芯片公司$Cerebras Systems$，因底层公司股价上涨，杠杆机制放大当日涨幅。该产品两倍做多Cerebras Systems，随标的走高，同步体现杠杆放大效应。$Corgi U.S. Regional Banks 2x Daily ETF$上涨12.03%。$Corgi META 2x Daily ETF$上涨12.00%。$AOT Software Platform ETF$上涨11.96%。美股ETF跌幅Top5$Defiance Daily Target 2X Long MRNA ETF$下跌21.77%。$Leverage Shares 2X Long OPEN Daily ETF$下跌20.38%。$罗素2000指数三倍做空ETF$上涨1.53%。$香港ETF-iShares MSCI$上涨1.37%。$核能指数ETF-Market Vectors$上涨1.23%。债券ETF涨幅Top 5$First Trust Emerging Markets L","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999018865.SGD","LU2381873111.SGD","IE00B1XK9C88.USD","LU2023250843.SGD","SPYH","LU0476273544.USD","LU0882574139.USD","LU1242518857.USD","LU0823421416.USD","LU0061475181.USD","LU0256863902.USD","USG","LU1670628061.USD","LU0096364046.USD","LU1861219969.SGD","LU0109392836.USD","LU0985320562.USD","NULC","OGIG","LU0061474705.USD","EBND","SG9999017495.SGD","LU0912757837.SGD","LU0345769128.USD","BK4139","LU2065171402.SGD","LU0096362180.USD","LU1670627923.USD","LU0127658192.USD","LU0820561909.HKD","BK4079","LU0070302665.USD","BK4096","LU1119994496.HKD","IE0003U64NQ7.SGD","LU0256863811.USD","LU0417517546.SGD","LU0724617625.USD","LU2505996509.AUD","IE00BFSS7M15.SGD","BK4606","LU0234572021.USD","LU0784383803.USD","LU1066053197.SGD","OIH","518880","UMDD","LU2720916845.USD","BAR","SG9999002224.SGD","AOTS","GLL","IE00BKDWB100.SGD","LU1815333072.USD","MADE","LU1861559042.SGD","LU0225283273.USD","LU0552385451.USD","LU2462157665.USD","BK4561","IE000W1ABFV2.USD","LU2417539215.USD","LU2543165471.USD","BK4603","JNUG","XLB","UYM","IE00B19Z3B42.SGD","LU2242650005.HKD","LU2602419157.SGD","GDXY","POWR","BEGS","LU1868836591.USD","LU2505996681.GBP","IE00BFSS8Q28.SGD","GDXD","METV","LU2430703095.HKD","LU0011850046.USD","LU2404859741.USD","LU1074936037.SGD","LU0320765059.SGD","IE0002270589.USD","RWM","SG9999001077.SGD","LU0784385840.USD","BGLD","BK4592","FGDL","SGXZ51526630.SGD","SPYU","UMAL","LU2552382132.HKD","XLC","PICK","BK4532","MRNA","LU1670711040.USD","BK7142","JDST","LU1261432733.SGD","LU2247934214.USD","IE00B19Z3581.USD","RING","LU0444973449.USD","HK0000914686.HKD","LU2264538146.SGD","IE00BJLML261.HKD","BK4533","IE000KEQY171.SGD","TWM","IE0034235303.USD","LU0203201768.USD","LU2125154778.USD","ELD","FCOM","IE00BD6J9T35.USD","LU2168564149.EUR","LU2272731865.HKD","LU1564329461.SGD","LU0823421333.USD","PSCM","SAA","NLR","LU2236285917.USD","LU0061474960.USD","LU1823568750.SGD","BK4562","LU0823434583.USD","XKRE","BK4548","LU2764262908.HKD","SGXZ31699556.SGD","LU0265550359.USD","LU0133085943.USD","LU1992135399.USD","EWH","LU2347655156.SGD","SH","LU0690374961.EUR","SG9999014906.USD","GDX","GLTR","IE00BQXX3C00.GBP","LU1316542783.SGD","SGXZ23171101.USD","GB00B4QBRK32.GBP","IE00B5949003.HKD","LU0265550946.USD","XDAT","LU0080751232.USD","IE00BK4W5M84.HKD","SGOL","NVOH","LU1489326972.SGD","LU1917777945.USD","FBX","LU2357125470.USD","LU0640476718.USD","LU1868836914.USD","GRID","LU0553294199.USD","LU1670711123.USD","LU1145028129.USD","EWZ","LU2168563687.JPY","LU2430703251.USD","DIG","LU2237957902.USD","SG9999014898.SGD","LU0788109477.HKD","LU0823414551.USD","BK4507","LU0642271901.SGD","LU0068578508.USD","IE00BWXC8680.SGD","DRN","SMAX","SPDN","SSO","LU1564329628.SGD","IE00B7KXQ091.USD","IE00B19Z9505.USD","LU1839511570.USD","LU1720051108.HKD","EMBD","GNOM","META","IE00BJJMRX11.SGD","LU0323591593.USD","LU2404859667.USD","DMAX","FDN","SG9999002232.USD","LU1301847155.USD","NVOX","LU2473716301.USD","LU0708995401.HKD","IE00BGHQF417.EUR","LU0079474960.USD","SPYQ","PALL","BK4568","LU1059921491.USD","BK4157","IE00B3CCJ633.GBP","BK4077","LU2322448791.USD","LU0648001328.SGD","UWM","GLDY","OUNZ","EMTL","HK0000914660.USD","UPRO","LU1116320737.USD","LU1674673691.USD","LU0097036916.USD","LU2860962120.EUR","IE00BMPRXR70.SGD","LU2357305700.SGD","LU2463028550.USD","LU1697837992.HKD","DUST","SPY","RSPC","VELL","BK4550","SG9999015978.USD","IE00BJJMRY28.SGD","LU0210533765.USD","LU0683600562.USD","CBRX","OPEG","LU1868836757.USD","LU0072461881.USD","LU2746668461.USD","LU2403377893.USD","IE00B4YYXB79.USD","DBP","SHNY","159831","IE00BJTD4V19.USD","LU2054465674.USD","LU0466842654.USD","IE00B3SWFQ91.USD","IE00BZ199S13.USD","LU2756315318.SGD","LU2506951792.HKD","YGLD","LU1791710400.SGD","LU1435385759.SGD","SPUU","LU1815336760.USD","FEMB","FBL","LU1732800096.USD","SPXS","LU0784385170.HKD","IE00BMPRXQ63.HKD","LU0889565833.HKD","LU0170899867.USD","LU0354030511.USD","LU1791710582.SGD","IVV","LU2317271919.USD","LU2125154935.USD","IE00B1BXHZ80.USD","OPEX","LU0203345920.USD","LU0528227936.USD","LU0198837287.USD","LU1699723380.USD","LU1127390331.HKD","LU0109391861.USD","BK4501","LU1803068979.SGD","LU1564329032.USD","LU0957808578.USD","BK4551","LU2294711713.HKD","LU2023250504.SGD","LU2746668974.SGD","LU2361045086.USD","LU0689472784.USD","LU0056508442.USD","IE00BJTD4N35.SGD","LU0006306889.USD","LU0353189763.USD","IE00B4JS1V06.HKD","KGLD","LU2360032135.SGD","LU2756315664.SGD","LU2106854487.HKD","SG9999015986.USD","LU0082616367.USD","LU2764263203.CNY","LU0154236417.USD","IE00BMPRXN33.USD","LU1153585028.USD","LU0545039389.USD","LU0070217475.USD","LU2347655073.USD","LU2458330169.SGD","GDXJ","LU1718418525.SGD","BK4524","LU1064131342.USD","LU2552382058.USD","SG9999014880.SGD","FBY","LU0820561818.USD","LU1571399168.USD","LU2322448957.HKD","BK4534","LU0719512351.SGD","LU0276348264.USD","LU1564329115.USD","LU2361044949.HKD","UMAC","NUGT","LU1232071149.USD","BK4588","ZAP","ETN","SG9999014914.USD","159934","LU2065169927.USD","LU0053666078.USD","LU2097829019.USD","BK4587","LU2360106780.USD","TNA","LU0316494557.USD","LU2023250330.USD","SDS","GB00BDT5M118.USD","LU1267930730.SGD","LU1814569148.SGD","NANR","LU0354030438.USD","IAUI","DULL","LU2237957811.SGD","LU1852331112.SGD","VOO","VOX","BK4543","LU2592432038.USD","LU1046421795.USD","VTWO","CEF","LU0786609619.USD","LU0979878070.USD","LU0949170426.SGD","IE000YTNTUN2.SGD","FAAR","LU1989764748.USD","LU1804176565.USD","LU2087621335.USD","IE0009G5SDU7.USD","LU2087625088.SGD","LU1267930490.SGD","LU0149725797.USD","BK4535","LU2249611893.SGD","YSPY","LU1642822529.SGD","LU1551013342.USD","LU1992135472.HKD","LU2063271972.USD","LU2272731600.USD","LU0174119429.USD","LU0985489474.SGD","LU1242518931.SGD","LU0211328371.USD","LU0726765562.USD","LU0310799852.SGD","LU1429558221.USD","IE0001KFT4U8.USD","LU1548497426.USD","LU0672654240.SGD","LU2326559502.SGD","LU2552382215.SGD","IE00BZ1G4Q59.USD","LU1366333091.USD","HIBL","LU1861558580.USD","LU2360107325.USD","DXJ","LU0208291251.USD","LU0345769631.USD","LU0980610538.SGD","IE0004445015.USD","LU0203202063.USD","IAU","LU2168564065.EUR","LU1720051017.SGD","BK4585","IE00B19Z8X17.USD","LU1116320901.HKD","LU0433182093.SGD","HK0000304797.USD","LU0353189680.USD","DGP","SGDM","LU0690374615.EUR","LU1069344957.HKD","METU","LU2462591350.SGD","SOCL","LU0215105999.USD","LU2213496289.HKD","GDXU","SPYM","GB00B4LPDJ14.GBP","IE00B19Z8W00.USD","URTY","LU0267386448.USD","IE00B2PGVK34.USD","IE00BN29S564.USD","LU0072462426.USD","LU1778281490.HKD","SPXL","LU2456880835.USD","IE00B7SZLL34.SGD","VELO","IE00BQXX3F31.USD","LU1988902786.USD","LU0878866978.SGD","EBND.AU","WDNA","LU2168564222.USD","LU2896262040.SGD","LU0210536198.USD","SG9999018857.SGD","LU2458330243.SGD","SGDJ","LU1732799900.SGD","LU1366192091.USD","IE000ITXATA3.USD","FBYY","UGL","LU0203347892.USD","SPXU","LU0320765489.SGD","LU2420271590.USD","GLDM","LU0314104364.USD","LU0820562030.AUD","LU0823434740.USD","LU1003077747.HKD","LU2250418816.HKD","LU1868837300.USD","LU0444971666.USD","SGXZ99366536.SGD","LU0738911758.USD","GLD","LU0211327993.USD","GOAU","BK4207","IE0004445239.USD","METW","LU0211331839.USD","LU1280957306.USD","LU0964807845.USD","GOLY","OPEN","LU0957791311.USD","LU0943347566.SGD","DGZ","CBRG","LU2168564495.EUR","LU1670710661.SGD","MVV","LU1670710588.SGD","IAUM","LU2065170008.USD","IE0009356076.USD","LU1496350502.SGD","BTGD","LU0795875169.SGD","HK0000304805.HKD","DZZ","IE00BQXX3D17.EUR","LU1861214812.USD","SGXZ81514606.USD","LU0795875086.SGD","LTL","MMAX","LU0823414478.USD","LU0130102774.USD","CBRS","LU1674673428.USD","TZA","LU2265009873.SGD","LU2065171311.SGD","IGLD","LU0106261372.USD","LU2430703178.SGD","DBC","MRNX","LGHT","LU1914381329.SGD","IE0034235188.USD","METD","LU0787776722.HKD","LU0784384876.USD","MIDU","LU1084165304.USD","LU1201861249.SGD","GBUG","XME","LU0308772762.SGD","IE00BKVL7J92.USD","LEMB","LU2461242641.AUD","PFFR","IE00BK4W5L77.USD","LU1989764664.SGD","SG9999015945.SGD","LU2361044865.SGD","AAAU","IDNA","LU1974910355.USD","XRT","BK4141","LU1551013425.SGD","LU0157215616.USD","LU2764263039.SGD","SG9999004303.SGD","LU0077335932.USD","LU1235294995.USD","EMLC","LU0234570918.USD","LU1035775433.USD","LU0949170772.SGD","BK4504","MRNY","SG9999015952.SGD","LU1629891620.HKD","LU2272731782.SGD","LU2487616109.SGD","IE0005OL40V9.USD","LU1868837136.USD","LU0661504455.SGD","LU2133065610.SGD","LU0348723411.USD","IWM","LU1066051498.USD","IE00B775H168.HKD","LU0210528500.USD","LU0162691827.USD","PHYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112712189","title":"ETF日報｜2倍沽空閃迪ETF 漲逾28%；三倍沽空半導體ETF 漲近17%；成長承壓、貴金屬走強","url":"https://stock-news.laohu8.com/highlight/detail?id=1112712189","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112712189?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 08:42","pubTimestamp":1783039362,"startTime":"0","endTime":"0","summary":"2倍做多AVAV ETF-Defiance上涨21.55%。美股ETF跌幅Top5Corgi ACLS 2x Daily ETF下跌37.68%。大盘指数ETF涨幅Top 5纳指三倍做空ETF上涨5.46%。大宗商品ETF涨幅Top 5二倍做多黄金矿业指数ETF-Direxion上涨8.61%。2倍做多黄金ETF-ProShares上涨4.08%。行业指数ETF涨幅Top 5三倍做空半导体ETF-Direxion Daily上涨16.84%。该产品三倍做空半导体板块，板块回落令反向产品大幅走高。债券ETF涨幅Top 5Infracap REIT Preferred ETF上涨1.20%。总结当日ETF结构显示科技成长承压，半导体多头显著回撤，做空半导体与做空纳斯达克100指数产品领涨。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e2482c489456454bb2227ec34bbeb7d8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWU","SQQQ","GDXJ","SOXS","UDOW","ACLZ","AVXX","SNDQ","EBND","IBB","IREZ","AEHG","EMLC","EWG","UGL","LEMB","AGQ","FOMG","UYM","GDX","DRN","PFFR","NUGT","VRP","FAS","APPC","UCTX","MRNX","QID","ACMM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1101034383","title":"莫德納股價因自身免疫性疾病新研究計劃而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=1101034383","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101034383?lang=zh_tw&edition=fundamental","pubTime":"2026-06-27 02:30","pubTimestamp":1782498636,"startTime":"0","endTime":"0","summary":"这家因信使RNA新冠疫苗而闻名的生物技术公司，正利用类似技术开发针对皮肤癌、肺癌及其他类型肿瘤的癌症疗法。在周四与分析师举行的会议上，公司高管透露了这一信息。此外，一项潜在的新型自身免疫性疾病疗法，采用了基于细胞的机制，即CAR-T技术。\n莫德纳股价周五上涨超过10%。此前，该公司公布了一项针对自身免疫性疾病的新治疗计划，并概述了多项实验性药物项目，这些项目有望在未来几年帮助其业务多元化，不再局限于新冠疫苗领域。\n今年以来，随着市场对该公司新药获批前景的乐观情绪升温，莫德纳股价已累计上涨超过一倍。这其中包括其与默克公司共同开发的一款实验性黑色素瘤疫苗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4532","BK4588","MRNY","MRNA","BK4139","MRNX","BK4534","BK4501","BK4568","BK4533","BK4585","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142868924","title":"Moderna股價因流感疫苗獲推薦而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=1142868924","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142868924?lang=zh_tw&edition=fundamental","pubTime":"2026-06-19 05:32","pubTimestamp":1781818378,"startTime":"0","endTime":"0","summary":"Moderna, Inc. 股价周四上涨3.5%，此前一个顾问委员会投票建议美国食品药品监督管理局批准这家生物技术公司针对50岁及以上人群提出的新型流感疫苗。\n美国食品药品监督管理局最初拒绝受理Moderna的疫苗审批申请，但在该公司修改申请后，同意进行审查。顾问委员会的赞成票虽不具约束力，但食品药品监督管理局通常会采纳此类建议。最终决定预计将在八月初做出。\n正试图拓展新冠疫苗以外业务的Moderna，其股价收盘时创下自2024年9月以来的最高水平。在过去六个交易日中，该股已累计上涨39%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4533","BK4532","BK4548","BK4588","MRNX","BK4568","BK4551","BK4585","MRNY","BK4139","BK4534","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163979178","title":"Moderna宣佈FDA諮詢委員會一致支持其季節性流感候選疫苗mRNA-1010的獲益-風險特徵","url":"https://stock-news.laohu8.com/highlight/detail?id=1163979178","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163979178?lang=zh_tw&edition=fundamental","pubTime":"2026-06-19 04:03","pubTimestamp":1781813033,"startTime":"0","endTime":"0","summary":"Moderna公司表示，美国食品药品监督管理局（FDA）的咨询委员会已一致投票，支持其研究性季节性流感疫苗mRNA-1010的获益-风险特征。这一积极进展为这款基于mRNA技术的流感疫苗后续的监管审评流程奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","MRNY","BK4532","BK4139","MRNX","BK4548","BK4533","BK4534","BK4551","BK4588","BK4585","BK4501","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124396230","title":"Moderna有意在德國設立生產基地 尤其關注BioNTech工廠","url":"https://stock-news.laohu8.com/highlight/detail?id=1124396230","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124396230?lang=zh_tw&edition=fundamental","pubTime":"2026-06-17 14:30","pubTimestamp":1781677818,"startTime":"0","endTime":"0","summary":"据行业消息透露，Moderna, Inc.正积极评估在德国建立生产设施的可能性，其目光尤其聚焦于BioNTech旗下的工厂资产。这一战略动向表明，这家在mRNA技术领域占据领先地位的生物技术公司，正寻求进一步拓展其全球生产网络，以加强在欧洲市场的供应链布局与产能弹性。德国作为欧洲生物医药制造的核心枢纽，其成熟的产业生态与高素质人才储备，无疑为Moderna的扩张计划提供了极具吸引力的落脚点。而对BioNTech现有生产设施的潜在兴趣，更凸显了行业内部资源整合与战略布局的新趋势。若相关洽谈取得进展，或将重塑欧洲mRNA疫苗及疗法的生产格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4532","BK4139","BK4534","MRNY","BK4501","BK4533","MRNX","BK4548","BK4568","BK4588","BK4551","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179067083","title":"FDA工作人員初步評估：Moderna流感疫苗數據或支持65歲及以上成人有效性","url":"https://stock-news.laohu8.com/highlight/detail?id=1179067083","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179067083?lang=zh_tw&edition=fundamental","pubTime":"2026-06-16 20:49","pubTimestamp":1781614183,"startTime":"0","endTime":"0","summary":"根据一份文件披露，美国食品药品监督管理局（FDA）工作人员已完成初步评估。其结论指出，Moderna公司提交的流感疫苗数据，可能为证明该疫苗对65岁及以上成年人群的有效性提供支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4532","BK4588","MRNY","MRNA","BK4139","MRNX","BK4534","BK4501","BK4568","BK4533","BK4585","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124334353","title":"Moderna組織架構調整 為2027及2028年多款產品上市鋪路","url":"https://stock-news.laohu8.com/highlight/detail?id=1124334353","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124334353?lang=zh_tw&edition=fundamental","pubTime":"2026-06-16 20:48","pubTimestamp":1781614130,"startTime":"0","endTime":"0","summary":"Moderna, Inc. 正着手进行一系列组织架构调整，旨在为2027年和2028年可能推出的多款新产品做好充分准备。公司预计，在这两年内，有望上市多达三款新疫苗，其中包括一款流感与新冠二合一疫苗、季节性流感疫苗以及诺如病毒疫苗。为了支持这一雄心勃勃的商业化蓝图，Moderna已任命埃斯特·班克为公司首席商务官，该任命自2026年6月15日起生效。这些战略举措清晰地勾勒出Moderna为即将到来的产品上市浪潮所做的系统性准备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BK4588","BK4551","BK4534","MRNA","MRNY","BK4501","BK4533","BK4568","BK4139","BK4548","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144697591","title":"Moderna預計2027至2028年可能推出多達三款新產品，涵蓋流感新冠聯合疫苗、季節性流感及諾如病毒疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1144697591","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144697591?lang=zh_tw&edition=fundamental","pubTime":"2026-06-16 19:33","pubTimestamp":1781609598,"startTime":"0","endTime":"0","summary":"Moderna, Inc. 近日透露，公司正积极布局未来产品线，预计在2027年至2028年间，可能有多达三款新疫苗产品有望上市。这些潜在的新品包括一款将流感与新冠病毒防护结合于一体的联合疫苗，一款针对季节性流感的更新疫苗，以及一款旨在预防诺如病毒感染的新型疫苗。市场分析人士指出，这一产品管线规划若顺利推进，将可能为Moderna在未来几年内打开新的增长空间，巩固其在全球生物技术及疫苗领域的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BK4534","BK4568","BK4585","BK4588","BK4532","BK4533","MRNA","BK4551","BK4501","BK4139","BK4548","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169654490","title":"Moderna任命Ester Banque為首席商務官，2026年6月15日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1169654490","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169654490?lang=zh_tw&edition=fundamental","pubTime":"2026-06-16 19:33","pubTimestamp":1781609595,"startTime":"0","endTime":"0","summary":"Moderna, Inc. 宣布，已任命Ester Banque为公司首席商务官，此项任命自2026年6月15日起正式生效。作为首席商务官，Banque将全面负责公司的全球商业战略、市场准入及销售运营，领导团队推动公司产品组合的商业化进程。此次高层人事变动旨在加强Moderna在全球商业运营方面的领导力，以应对不断变化的市场环境并把握未来的增长机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BK4588","BK4551","BK4534","MRNA","MRNY","BK4501","BK4533","BK4568","BK4139","BK4548","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155700158","title":"Moderna總裁斯蒂芬·霍格擴大職責範圍，將負責傳染病、Intismeran及罕見病業務板塊的運營監督","url":"https://stock-news.laohu8.com/highlight/detail?id=1155700158","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155700158?lang=zh_tw&edition=fundamental","pubTime":"2026-06-16 19:33","pubTimestamp":1781609594,"startTime":"0","endTime":"0","summary":"Moderna公司宣布，其总裁斯蒂芬·霍格将承担更广泛的职责，负责监督公司传染病业务、Intismeran以及罕见病业务板块的运营工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4568","BK4501","BK4548","BK4534","BK4551","MRNA","BK4139","BK4588","BK4585","MRNX","MRNY","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159808781","title":"Moderna與CEPI深化戰略合作 共同推進布迪布焦埃博拉病毒候選疫苗研發","url":"https://stock-news.laohu8.com/highlight/detail?id=1159808781","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159808781?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 17:04","pubTimestamp":1780304697,"startTime":"0","endTime":"0","summary":"Moderna, Inc.与流行病防范创新联盟（CEPI）宣布，双方将扩大战略合作，旨在加速推进针对布迪布焦埃博拉病毒的潜在疫苗研发进程。此次合作扩展标志着双方在应对新兴传染病威胁方面的持续承诺，旨在利用Moderna的mRNA技术平台，开发针对这一特定埃博拉病毒株的疫苗候选产品。双方的合作将涵盖从早期研发到可能的生产准备等多个阶段，以期在全球卫生安全领域做出贡献。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4534","BK4501","BK4533","BK4551","MRNY","BK4139","MRNA","BK4548","BK4568","BK4532","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100185800","title":"Moderna獲CEPI高達5000萬美元資助，用於推進BDBV候選疫苗臨床前研發與一期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1100185800","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100185800?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 17:03","pubTimestamp":1780304598,"startTime":"0","endTime":"0","summary":"Moderna, Inc. 宣布，流行病防范创新联盟（CEPI）已承诺提供高达5000万美元的资金，以支持该公司针对布尼亚病毒科（Bunyavirales）的候选疫苗的临床前开发及一期临床试验。\n这笔重要的资金注入将加速该研究性疫苗的研发进程，涵盖从实验室研究到初步人体安全性与免疫反应评估的关键阶段。Moderna将利用其在mRNA技术平台上的专业优势，推进这一针对潜在公共卫生威胁的预防性疫苗的开发工作。\n此次合作凸显了全球卫生组织与生物技术公司携手应对新兴传染病威胁的共同努力。资金的到位为候选疫苗的早期研发提供了关键资源，有望推动其向更广泛的临床测试阶段迈进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","MRNY","BK4532","BK4534","BK4588","BK4501","BK4139","MRNX","BK4551","BK4568","BK4585","BK4533","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139235440","title":"美國FDA顧問投票支持建議2026-27年度新冠疫苗以Jn.1譜系Xfg變異株為靶點","url":"https://stock-news.laohu8.com/highlight/detail?id=1139235440","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139235440?lang=zh_tw&edition=fundamental","pubTime":"2026-05-29 02:28","pubTimestamp":1779992883,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局的疫苗顾问小组已投票支持一项建议，即在2026-2027年度的新冠疫苗接种活动中，应将疫苗的靶点更新为当前流行的Jn.1谱系Xfg变异株。这一决定标志着公共卫生机构在应对病毒持续演变方面迈出了关键一步。相关企业可能需要据此调整其疫苗成分，以符合新的公共卫生指导。随着病毒变异，疫苗的定期更新已成为新常态，以确保其防护效力。最终决定权仍在FDA，但通常其会采纳顾问委员会的建议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU0225284248.USD","BK4548","BK4501","LU1883839398.USD","NVAX","BK4532","SG9999002224.SGD","LU1057294990.SGD","SG9999013999.USD","IE00B19Z3581.USD","LU0456855351.SGD","LU0868494617.USD","SG9999003800.SGD","BK4581","SG9999011175.SGD","MRNA","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU0225771236.USD","LU0985481810.HKD","BK4550","LU1894683264.USD","BK4534","BK4547","LU0321505439.SGD","BK4551","SGXZ57979304.SGD","IE0002270589.USD","LU1894683348.USD","SG9999001176.SGD","BK4139","IE00BBT3K403.USD","BK4533","IE00BLSP4239.USD","LU0170899867.USD","BK4592","LU0306807586.USD","MRNX","BK4599","LU0058720904.USD","LU0234572021.USD","BK4568","BK4588","IE00B3T34201.USD","LU1023059063.AUD","BK4585","IE000M9KFDE8.USD","BK4007","SG9999001176.USD","LU0122379950.USD","SG9999002232.USD","PFE","LU0306806265.USD","MRNY","LU0289739699.SGD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158347106","title":"Moderna公司計劃於八月中旬前備妥2026-27年度推薦新冠疫苗組分供應","url":"https://stock-news.laohu8.com/highlight/detail?id=1158347106","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158347106?lang=zh_tw&edition=fundamental","pubTime":"2026-05-28 20:19","pubTimestamp":1779970758,"startTime":"0","endTime":"0","summary":"根据最新简报文件披露，Moderna公司已做好充分准备，预计将在八月中旬之前完成针对2026-27年度推荐新冠疫苗组分的生产供应部署。这一时间节点对于确保秋季疫苗接种计划的顺利推进具有关键意义，显示出该公司在应对公共卫生需求方面的前瞻性布局能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4533","BK4532","BK4548","BK4588","MRNX","BK4568","BK4551","BK4585","MRNY","BK4139","BK4534","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143160264","title":"個股聚焦：Moderna、英特爾、MidCap Financial Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=1143160264","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143160264?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 17:46","pubTimestamp":1778492797,"startTime":"0","endTime":"0","summary":"Moderna 股价在盘前交易中飙升了8%。此前，这家生物医药公司向媒体透露，早在近期一艘邮轮爆发疫情之前，他们就已经启动了针对汉坦病毒的疫苗研发工作。市场对人工智能相关企业的热情持续高涨，推动这两家芯片制造商的股价双双上扬。就在上周五，它们的收盘价均创下了历史新高。据消息，阿波罗全球管理 已就出售其上市业务发展公司 MidCap Financial Investment Corp 进行了谈判。福克斯-A 则是今日计划公布财报的公司之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0642271901.SGD","LINT","LU2054465674.USD","MRNA","LU0203347892.USD","LU0889565833.HKD","BK4501","BK4548","BK4554","LU0321505439.SGD","MUU","LU0109392836.USD","BK4515","LU0321505868.SGD","BK4527","BK4575","BK4568","BK4135","LU1852331112.SGD","INTW","MRNY","LU2148611432.USD","BK4532","LU0056508442.USD","LU1316542783.SGD","BK4529","BK4533","BK4602","LU0082616367.USD","LU2089985449.USD","BK4579","BK4141","MULL","BK4612","LU1323610961.USD","LU2048586759.USD","IE000M9KFDE8.USD","LU0097036916.USD","FOXA","BK4585","INTC","LU0792757196.USD","IE00B5949003.HKD","LU1803068979.SGD","IE0009356076.USD","LU0203345920.USD","LU2360106780.USD","MFIC","IE00B19Z3581.USD","LU2211815571.USD","BK4605","BK4125","BK4534","LU0274383776.USD","LU0889566641.SGD","LU1366333091.USD","LU0157215616.USD","LU2543165471.USD","LU2458330169.SGD","BK4543","IE00B19Z3B42.SGD","BK4551","IE00B7SZLL34.SGD","LU0719512351.SGD","MU","LU0154236417.USD","GB00BDT5M118.USD","APO","LU2286300806.USD","BK4139","BK4588","MUD","IE0002270589.USD","LU1267930813.SGD","BK4512","LU0081259029.USD","MRNX","LU2931357623.SGD","LU2458330243.SGD","BK4550","BK4566","BK4535","LU0127658192.USD","BK4553","LU2250418816.HKD","04335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151344645","title":"Moderna國際新冠疫苗銷售超預期 一季度業績亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1151344645","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151344645?lang=zh_tw&edition=fundamental","pubTime":"2026-05-01 22:26","pubTimestamp":1777645603,"startTime":"0","endTime":"0","summary":"得益于长期政府合作框架下的国际新冠疫苗销售，Moderna第一季度营收实现逾三倍增长，达到3.89亿美元。\n这家位于马萨诸塞州剑桥的生物技术公司公布，三月季度净亏损13亿美元。若剔除与新冠疫苗技术诉讼和解相关的约9亿美元支出，经调整后亏损收窄至4.65亿美元，这一表现优于分析师预期。\n股价在盘前交易中曾强势上扬，但开盘后小幅走低。\nModerna正等待美国食品药品监督管理局于八月初对其首款独立流感疫苗的审批结果。此外，针对黑色素瘤的个性化癌症疫苗三期临床试验数据预计将于今年晚些公布，该疗法有望开创疾病治疗新路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4568","BK4533","MRNA","BK4551","BK4534","MRNY","MRNX","BK4501","BK4588","BK4139","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150823990","title":"Moderna高管稱公司正等待FDA指導 以恢復流感-新冠聯合疫苗美國申報流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1150823990","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150823990?lang=zh_tw&edition=fundamental","pubTime":"2026-05-01 20:24","pubTimestamp":1777638268,"startTime":"0","endTime":"0","summary":"Moderna公司高管近日表示，该公司正在等待美国食品药品监督管理局的进一步指导，以确定恢复流感与新冠联合疫苗在美国申报的后续步骤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4534","BK4501","BK4533","BK4551","MRNY","BK4139","MRNA","BK4548","BK4568","BK4532","MRNX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":55,"code":"91000000","status":"200"}]}}